Celecoxib Orion 200 mg Kapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

celecoxib orion 200 mg kapsel, hård

aurobindo pharma (malta) limited - celecoxib - kapsel, hård - 200 mg - celecoxib 200 mg aktiv substans; natriumlaurilsulfat hjälpämne; laktosmonohydrat hjälpämne

Celecoxib Orion 100 mg Kapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

celecoxib orion 100 mg kapsel, hård

aurobindo pharma (malta) limited - celecoxib - kapsel, hård - 100 mg - celecoxib 100 mg aktiv substans; laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne

Avolve 0,5 mg Kapsel, mjuk Sverige - svenska - Läkemedelsverket (Medical Products Agency)

avolve 0,5 mg kapsel, mjuk

glaxosmithkline (ireland) limited - dutasterid - kapsel, mjuk - 0,5 mg - glycerol hjälpämne; dutasterid 0,5 mg aktiv substans; butylhydroxitoluen hjälpämne - dutasterid

Comirnaty Europeiska unionen - svenska - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. användning av detta vaccin bör ske i enlighet med officiella rekommendationer.

Duagen 0,5 mg Kapsel, mjuk Sverige - svenska - Läkemedelsverket (Medical Products Agency)

duagen 0,5 mg kapsel, mjuk

glaxosmithkline (ireland) limited - dutasterid - kapsel, mjuk - 0,5 mg - glycerol hjälpämne; dutasterid 0,5 mg aktiv substans; butylhydroxitoluen hjälpämne - dutasterid

Avodart 0,5 mg Kapsel, mjuk Sverige - svenska - Läkemedelsverket (Medical Products Agency)

avodart 0,5 mg kapsel, mjuk

medartuum ab - dutasterid - kapsel, mjuk - 0,5 mg - butylhydroxitoluen hjälpämne; propylenglykol hjälpämne; dutasterid 0,5 mg aktiv substans; glycerol hjälpämne - dutasterid

Avodart 0,5 mg Kapsel, mjuk Sverige - svenska - Läkemedelsverket (Medical Products Agency)

avodart 0,5 mg kapsel, mjuk

paranova läkemedel ab - dutasterid - kapsel, mjuk - 0,5 mg - propylenglykol hjälpämne; dutasterid 0,5 mg aktiv substans; butylhydroxitoluen hjälpämne; glycerol hjälpämne - dutasterid

Avodart 0,5 mg Kapsel, mjuk Sverige - svenska - Läkemedelsverket (Medical Products Agency)

avodart 0,5 mg kapsel, mjuk

paranova läkemedel ab - dutasterid - kapsel, mjuk - 0,5 mg - dutasterid 0,5 mg aktiv substans; propylenglykol hjälpämne; glycerol hjälpämne; butylhydroxitoluen hjälpämne - dutasterid

Avodart 0,5 mg Kapsel, mjuk Sverige - svenska - Läkemedelsverket (Medical Products Agency)

avodart 0,5 mg kapsel, mjuk

orifarm ab - dutasterid - kapsel, mjuk - 0,5 mg - dutasterid 0,5 mg aktiv substans; propylenglykol hjälpämne; butylhydroxitoluen hjälpämne; glycerol hjälpämne - dutasterid

Avidart 0,5 mg Kapsel, mjuk Sverige - svenska - Läkemedelsverket (Medical Products Agency)

avidart 0,5 mg kapsel, mjuk

paranova läkemedel ab - dutasterid - kapsel, mjuk - 0,5 mg - propylenglykol hjälpämne; glycerol hjälpämne; butylhydroxitoluen hjälpämne; dutasterid 0,5 mg aktiv substans - dutasterid